These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 23787453)
1. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage. Göncü T; Özdek S; Ünlü M Eur J Ophthalmol; 2014; 24(1):88-93. PubMed ID: 23787453 [TBL] [Abstract][Full Text] [Related]
2. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage? Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H Eur J Ophthalmol; 2009; 19(4):618-21. PubMed ID: 19551678 [TBL] [Abstract][Full Text] [Related]
3. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy. Ahn J; Woo SJ; Chung H; Park KH Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study. Park DH; Shin JP; Kim SY Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531 [TBL] [Abstract][Full Text] [Related]
6. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage. Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA Retina; 2010; 30(10):1646-50. PubMed ID: 20634777 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study. Jirawison C; Ittipunkul N J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866 [TBL] [Abstract][Full Text] [Related]
8. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment. Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872 [TBL] [Abstract][Full Text] [Related]
9. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage. Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy. Yeh PT; Yang CH; Yang CM Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118 [TBL] [Abstract][Full Text] [Related]
11. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332 [TBL] [Abstract][Full Text] [Related]
12. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study. Jiang T; Gu J; Zhang P; Chen W; Chang Q BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913 [TBL] [Abstract][Full Text] [Related]
13. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy. Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852 [TBL] [Abstract][Full Text] [Related]
14. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Yang CM; Yeh PT; Yang CH; Chen MS Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Modarres M; Nazari H; Falavarjani KG; Naseripour M; Hashemi M; Parvaresh MM Eur J Ophthalmol; 2009; 19(5):848-52. PubMed ID: 19787608 [TBL] [Abstract][Full Text] [Related]
16. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab. Hu X; Pan Q; Zheng J; Song Z; Zhang Z BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158 [TBL] [Abstract][Full Text] [Related]
17. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY. Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549 [TBL] [Abstract][Full Text] [Related]
18. Anterior retinal cryotherapy and intravitreal injection of bevacizumab in the treatment of nonclearing vitreous hemorrhage in proliferative diabetic retinopathy. Hsieh MC; Yeh PT; Yang CM; Yang CH J Ocul Pharmacol Ther; 2014 May; 30(4):353-8. PubMed ID: 24359129 [TBL] [Abstract][Full Text] [Related]